Second Sight Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for Second Sight Medical Products are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 15, 2019 and ending today October 13, 2019. Click here to learn more.

Second Sight Profile

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 123 people. more
Second Sight Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
Second Sight Medical SEC Filings
Second Sight SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameSecond Sight Medical Products
President CEO, DirectorJonathan McGuireView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationCalifornia U.S.A
Business Address12744 San Fernando Road
ExchangeBATS Exchange
CIK Number0001266806
CUSIP81362J100
Older SymbolEYESW
SectorHealthcare
IndustryMedical Devices
BenchmarkDOW
Websitewww.secondsight.com
Phone818 833 5000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019
Second Sight Medical Products (EYES) is traded on BATS Exchange in USA. It is located in 12744 San Fernando Road and employs 123 people. Second Sight Medical Products was previously known as Second Sight Medical Products Inc Warrants and was traded on BATS Exchange under the symbol EYESW. Second Sight is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 115.24 M. Second Sight Medical conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 124.59 M outstanding shares of which 4.7 M shares are currently shorted by private and institutional investors with about 32.84 trading days to cover. Second Sight Medi currently holds about 25.16 M in cash with (28.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Check Second Sight Probability Of Bankruptcy

Ownership Allocation (%)

Second Sight Target Price Odds Analysis

Odds Below 0.8095HorizonTargetOdds Above 0.8095
38.19%30 days 0.81 61.61%
Based on normal probability distribution, the odds of Second Sight to move above current price in 30 days from now is about 61.61 (This Second Sight Medical Products probability density function shows the probability of Second Sight Stock to fall within a particular range of prices over 30 days) .

Second Sight Medical Top Holders

Second Sight Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Versant Venture Management LlcCommon Shares4.5 M3.7 M
Wiley Brosaintree Capital LlcCommon Shares52 K43 K
Wiley Brosaintree Capital LlcWarrants22 KK
View Second Sight Diagnostics

Second Sight Medical Products Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Second Sight Key Fundamentals

Second Sight Against Markets

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Second Sight Upcoming and Recent Events

Second Sight Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportNovember 6, 2019
Next Earnings ReportMarch 11, 2020
Next Fiscal Quarter EndSeptember 30, 2019
Next Fiscal Year EndMarch 11, 2020
Last Quarter Report DateJune 30, 2019
Last Earning Anouncement DateSeptember 30, 2018

Second Sight Corporate Filings

Second Sight Corporate Filings

Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
Unclassified Corporate Event
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Other Events

Second Sight Corporate Directors

Gregg Williams Independent Director
William Link Independent Director
James Miller Director - Manufacturing
Additionally see Investing Opportunities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com